Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Entecavir price, strengths & recalls

Generic of Baraclude

Pharmacies pay $7.38 for 30 tablets of Entecavir 0.5 mg tablet this week, and from $7.38 to $10.74 across its 2 priced strengths and forms. 11 manufacturers make it. 4 recalls are ongoing. Its official label last changed on January 13, 2025.

4 open recallsGeneric
Pharmacies pay$7.38for 30 tablets of 0.5 mg tablet+12.6% in 4 weeks
Fair cash price
$18.99
Strengths
2
Makers
11
Updated
Nov 11

Entecavir price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.5 mg tablet$0.2460$7.38 / 30 tablets+12.6%+1.8%
1 mg tablet$0.3579$10.74 / 30 tablets-2.9%-23.6%

Brand names of entecavir

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
4 ongoing recalls6 recalls on record, latest Oct 8, 2025

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for entecavir? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJanuary 13, 2025
Version4 of 4
EffectiveJan 9, 2025
Read the label

These highlights do not include all the information needed to use ENTECAVIR TABLETS safely and effectively. See full prescribing information for ENTECAVIR TABLETS. ENTECAVIR tablets, for oral use Initial U.S. Approval: 2005

This drug has a boxed warning

WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, AND LACTIC ACIDOSIS AND HEPATOMEGALY

WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY

Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted

[see Warnings and Precautions (

5.1)].

Limited clinical experience suggests there is a potential for the development of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitors if entecavir is used to treat chronic hepatitis B virus (HBV) infection in patients with HIV infection that is not being treated. Therapy with entecavir is not recommended for HIV/HBV co-infected patients who are not also receiving highly active antiretroviral therapy (HAART)

[see Warnings and Precautions (

5.2)].

Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors alone or in combination with antiretrovirals

[see Warnings and Precautions (

5.3)].

WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY

See full prescribing information for complete boxed warning.•

Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely for at least several months after discontinuation. Initiation of anti-hepatitis B therapy may be warranted. (

5.1)

•

Entecavir is not recommended for patients co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) who are not also receiving highly active antiretroviral therapy (HAART), because of the potential for the development of resistance to HIV nucleoside reverse transcriptase inhibitors. (

5.2)

• Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors. (

5.3)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021797 · Bristol Myers Squibb
First approved
March 29, 2005 (21 years ago)
Latest approved change
August 18, 2026
Approved label
PDF, Aug 20, 2026
Generic makers
8 approved generic applications on the market

Entecavir questions

How much does entecavir cost without insurance?

Pharmacies pay about $7.38 for 30 tablets of entecavir 0.5 mg tablet ($0.2460 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $18.99. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of entecavir?

Entecavir is sold as Baraclude. The generic has the same active ingredient and usually costs far less.

Is entecavir in shortage?

No shortage is reported for entecavir right now. We check the national shortage list every day.

Has entecavir been recalled?

6 recalls on record, 4 ongoing. Recalls name specific lots - check yours.

When did the entecavir label last change?

The official label was last updated on January 13, 2025 (version 4). See what changed.

Talk about entecavir

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.